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Development of the lip and palate involves a complex series of events that requires
the close co-ordination of cell migration, growth, differentiation, and apoptosis. Palatal
shelf elevation is considered to be driven by regional accumulation and hydration of
glycosoaminoglycans, principally hyaluronan (HA), which provides an intrinsic shelf force,
directed by components of the extracellular matrix (ECM). During embryogenesis, the
extracellular and pericellular matrix surrounding migrating and proliferating cells is rich
in HA. This would suggest that HA may be important in both shelf growth and fusion.
TGFβ3 plays an important role in palatogenesis and the corresponding homozygous null
(TGFβ3−/−) mouse, exhibits a defect in the fusion of the palatal shelves resulting in
clefting of the secondary palate. TGFβ3 is expressed at the future medial edge epithelium
(MEE) and at the actual edge epithelium during E14.5, suggesting a role for TGFβ3
in fusion. This is substantiated by experiments showing that addition of exogenous
TGFβ3 can “rescue” the cleft palate phenotype in the null mouse. In addition, TGFβ1
and TGFβ2 can rescue the null mouse palate (in vitro) to near normal fusion. In vivo
a TGFβ1 knock-in mouse, where the coding region of the TGFβ3 gene was replaced
with the full-length TGFβ1 cDNA, displayed complete fusion at the mid portion of the
secondary palate, whereas the anterior and posterior regions failed to fuse appropriately.
We present experimental data indicating that the three HA synthase (Has) enzymes
are differentially expressed during palatogenesis. Using immunohistochemistry (IHC) and
embryo sections from the TGFβ3 null mouse at days E13.5 and E14.5, it was established
that there was a decrease in expression of Has2 in the mesenchyme and an increase in
expression of Has3 in comparison to the wild-type mouse. In vitro data indicate that HA
synthesis is affected by addition of exogenous TGFβ3. Preliminary data suggests that this
increase in HA synthesis, in response to TGFβ3, is under the control of the PI3kinase/Akt
pathway.
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INTRODUCTION
Palatogenesis is a developmental event which starts at week 4
in human embryonic development and is not completed until
around week 12 (Mossey et al., 2009); and is comprised of two
main events i.e. formation of the primary and the secondary
palate. The focus of this study will be the events implicated in
formation of the secondary palate. The palatal shelves grow in
a vertical orientation following the influx of mesenchymal cells
at the maxillary process. There are two particularly important
events in secondary palatogenesis: palatal shelf elevation and
palatal shelf fusion (Mossey et al., 2009). Historically, it was
believed that during palatal shelf elevation in mice, the epithe-
lial area at the tip of the vertical palatal shelf would rotate
above the tongue to become the medial edge epithelium (MEE)
(Gritli-Linde, 2007). However, alternative methods have also been
muted such as, a “flowing” movement (Greene and Kochhar,
1973; Diewert and Tait, 1979) and the production of an out-
growth from the side of the palatal shelf so that the MEE is
composed of epithelial cells from the edge of the palatal shelves
nearest the tongue (Jin et al., 2010). It has also been suggested
that the most anterior and posterior region of the palate have
a different method of changing palatal shelf orientation than
the mid-palate. It is reported that the mid-palate elevates by
rotation and remodeling the medial edge of the shelf, in accor-
dance with the thoughts of Jin et al. (2010), while the front and
back portions of the palate develop new tissue by remodeling.
Once the shelves have elevated, they grow toward each other,
the shelves touch and form a mid-line epithelial seam which
then disappears to form the completely fused secondary palate
(Mossey et al., 2009).
Cleft palates are a common developmental abnormality
with around 1–2 per 1000 births affected (Christensen, 2002).
Unfortunately, the molecular events involved in palatogenesis are
currently poorly understood, thus there are no clear ways of pre-
venting the development of oral clefts. It is therefore essential that
research into the mechanisms involved in abnormal palatogenesis
is carried out, as a cleft palate can have a marked affect a patient’s
quality of life (Marcusson et al., 2001).
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The TGFβ family consists of more than 30 proteins (Nawshad
et al., 2005). These proteins are involved in numerous biological
processes including, proliferation, differentiation, and apoptosis,
as well as epithelial-mesenchymal transition (EMT), extracellu-
lar matrix (ECM) synthesis and deposition (Martinez-Alvarez
et al., 2000). There are three human isoforms; TGFβ1, TGFβ2, and
TGFβ3, which are all expressed in the epithelium of the palatal
shelves at different stages of palatogenesis (Meng et al., 2009).
Although the isoforms are known to share approximately 71–76%
sequence homology, their roles in embryogenesis (and after) vary
significantly (Rotzer et al., 2001). Their specific function is highly
dependent upon which member of the TGFβ family is activated.
For example, for EMT, TGFβ1 activation occurs in cancer, while
activation of TGFβ3 occurs during development (Yu et al., 2009).
Hyaluronan (HA) is a high molecular mass polysaccharide
consisting of D-glucuronic acid (1-β3) N-acetyl D-glucosamine
(1-β4) disaccharide repeats (Ellis et al., 1997). Unlike other gly-
cosaminoglycans (GAGs), HA is not synthesized within the Golgi
apparatus, but at the plasma membrane by the addition of
UDP-Glucuronic acid and UDP-N-acetyl glucosamine on mem-
brane bound enzymes known as HA synthases (Has) (Moffatt
et al., 2011). These enzymes synthesize HA and secrete it directly
through the plasma membrane into the extracellular environ-
ment (Moffatt et al., 2011). The Has family is comprised of three
members; Has1, Has2, and Has3, which are all composed of a
transmembrane domain and a large cytosolic catalytic domain
(Laurent and Fraser, 1992; Weigel et al., 1997; Moffatt et al.,
2011). However, they differ in their stability, in the time they are
expressed during development (Tien and Spicer, 2005), their level
of expression in different cell types, with growing cells expressing
higher levels than those that are not (Jacobson et al., 2000) and the
way they are affected by external stimuli (Ellis et al., 2007). Each
of the Has produces HA with the same structure, but with vari-
ousmolecular weights, thus allowing cells to utilize HA differently
(Itano et al., 1999) (Table 1). As the Has enzymes are impor-
tant in many processes during and following development, they
must be strictly regulated. This may occur post-transcriptionally
by inhibition of translation by naturally occuring anti-sense Has2
(Nishida et al., 2005; Michael et al., 2011), dimersation of the
Has enzymes, modification of the enzymes through monoubiq-
uitination, the ABC transport system which moves HA into the
ECM and the effect of certain lipids making up the plasma mem-
brane (Karousou et al., 2010). Furthermore, regulation may occur
through increased or decreased levels of the sugar substrates
needed for HA production (Ventura et al., 2006). The rate at
which the enzymes are translated may also be important (Recklies
et al., 2001).
Previous studies have reported a link between HA and TGFβ3
in wound healing. The roles of HA and TGFβ3 have also been
linked to scarless wound healing. Longaker et al. (1991), suggest
that HA may be vital in providing foetal cells with an environ-
ment for scarless wound healing, as it is present for much longer
in foetal cells compared to the short initial presence in adult cells.
Furthermore, HAmay be able to prevent or reduce adult scar for-
mation through exogenous application (Hellstrom and Laurent,
1987; Shah et al., 1995) speeding up the process of wound heal-
ing (Laurent and Fraser, 1992). It could therefore be possible
that a common pathway involving TGFβ3 and HA is involved in
scarless wound healing which is a throwback to the early link in
developmental processes such as secondary palate formation.
Our working hypothesis is that HA has a role in normal palato-
genesis both in terms of hydration, enabling shelf elevation and
as a matrix for cell migration and proliferation. Perturbation of
growth factors such as TGFβ3 and EGF lead to reduced synthesis
of HA (or changes in the size of HA produced) and can lead to the
formation of a cleft palate.
MATERIALS AND METHODS
IMMUNOHISTOCHEMISTRY (IHC)
Coronal tissue sections of wild-type and TGFβ3 null mouse
embryo crania (C57 strain), fixed in 4% (v/v) paraformalde-
hyde, were a gift from Professor M. Dixon (Manchester Dental
School). After fixing and pre-treatment with citrate buffer (pH6)
at 95◦C, the tissue sections were stained using a method based
on that described in Jones et al. (2007). Normal swine serum
(20% v/v in PBS, Vector) was used to block non-specific stain-
ing in sections to be stained for Has1 and Has2 and nor-
mal goat serum (20% v/v in PBS, Vector) was used to block
Table 1 | Differences between the Has enzymes.
Has1 Has2 Has3
Gene Location in Humans
(Spicer et al., 1997)
Boundary of 19q13.3 and 19q13.4 8q24.12 16q22.1
Gene Location in Mice (Spicer
et al., 1997)
Chromosome 17 Chromosome 15 Chromosome 8
Expression-mRNA (Tien and
Spicer, 2005)
During gastrulation. Stopped by
E8.5 in mice
At all times during development.
The only Has expressed in the
elevating palatal shelves
After E10.5 in mice. The only Has
present in the dental epithelial
placode
Stability (Tien and Spicer, 2005) Least stable Intermediate stability Most stable
Molecular Weight of HA
Produced (Itano et al., 1999)
Between 2 × 105 and 2× 106 Da Between 2 × 105 and 2× 106 Da Between 1 × 105 and 1 × 106 Da
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sections to be stained for Has3. Following optimization, the
Has1, Has2, and Has3 primary antibodies (sc23145, sc34068,
sc66917, Santa Cruz Biotechnology) were used at a concentra-
tion of 2μg/ml. Biotinylated swine anti-goat (DakoCytomation,
Glostrup, Denmark) and biotinylated goat anti-rabbit (Vector,
Burlingame, USA) secondary antibodies were used at concen-
trations of 1:150 and 1:166 respectively. Primary antibody only,
secondary antibody only and blocking peptides for sc34068
and sc66916 (Santa Cruz Biotechnology) were used as nega-
tive controls. Staining was visualized using an avidin-biotinylated
enzyme complex (Vectastain ABC kit, Standard Elite, Vector
Labs.) and incubation with DAB (3′,3′-diaminobenzidine), a
substrate for the enzyme. Sections were counter-stained with
haematoxylin.
3D COLLAGEN GEL MIGRATION ASSAY
Type I collagen from rat tail tendons was used to make 2ml col-
lagen gels in 35mm plastic tissue culture dishes as previously
described (Ellis et al., 2010). Collagen gels were overlaid with 1ml
of either serum-free MEM (SF-MEM) or SF-MEM containing 4×
the final concentration of the test compounds to be examined.
Confluent stock cultures of fibroblasts were then harvested, resus-
pended in growth medium containing 4% (v/v) donor calf serum
at 2 × 105 cells/ml and 1ml aliquots were added to the overlaid
gels. Considering the 2ml volume of gel, 1ml medium overlay
and 1ml cell inoculums, this procedure gives a final concentration
of 1% (v/v) serum in both control and test cultures. Fibroblasts
attach to the surface of the gel within 1 h and start migrating into
the underlying 3D gel within 24 h. Four days after plating, the
number of cells that remain on the surface or migrate into the
gel was determined by microscopic observation of 10 randomly
selected fields in each of duplicate cultures (Ellis et al., 2010).
Cell migration was then expressed by the number of cells that
migrated into the 3D gel, as a percentage of the total number of
cells present (mean ± SEM).
METABOLIC LABELING AND DETERMINATION OF TOTAL LABELED HA
GAGs synthesized by adult and foetal fibroblasts were metabol-
ically labeled by incubating cultures with 2.5μCi ml−1 of [3H]-
glucosamine for 4 days. Metabolically labeled cell cultures were
then separated into medium and pericellular fractions (Ellis et al.,
1992). For cells plated onto collagen gels, the medium and gel
were transferred to a centrifuge tube and spun at 3000 rpm for
20min at 4◦C. The medium was removed and the compacted
gel resuspended in 2ml of phosphate-buffered-saline (PBS).
Centrifugation was repeated and the supernatant was then com-
bined with the previous one, to form the medium fraction. The
pericellular fraction was obtained by extracting the cell layer with
2ml 4M-guanidinium chloride, 50mM-Tris, pH 7.4, for 24 h at
4◦C. The insoluble material was removed by centrifugation at
12,000 g for 2min in a microcentrifuge and the supernatant was
collected as the pericellular fraction. The medium and pericel-
lular fractions were dialyzed against 0.1M sodium acetate, 5mM
EDTA, pH 5.5 for 48 h (with two changes per day). For cells plated
on plastic tissue culture dishes, the medium was transferred to
a centrifuge tube. The dish was then washed with 2 × 1ml PBS
which was added to the medium. The cells on the dish were
extracted in the same manner as the cells on the collagen gel, as
described above.
The dialysate volumes were measured and six 200μl aliquots
were taken of each sample. 20μl of hyaluronate lyase (final con-
centration 0.5U/ml in acetate buffer) was added to three of these,
whilst 20μl of acetate buffer was added to the three remaining
controls. All samples were incubated for 17 h at 37◦C, then boiled
for 1min to inactivate the enzyme and unlabeled carrier GAG
added (30μl 1% chondroitin sulphate/0.5% HA in PBS). The
undigested GAGswere precipitated with 4 volumes of 1.3% potas-
sium acetate in 100% ethanol at −20◦C for 3 h (Underhill and
Toole, 1979). The precipitate was sedimented by centrifugation at
12,000 g for 5min, the supernatant was again removed and the
pellet redissolved in 100μl of 1M sodium hydroxide and boiled
for 3min. The sodium hydroxide was neutralized with 100μl
of 1M hydrochloric acid. The GAGs were transferred to scin-
tillation vials had 1ml of scintillant added and the radioactivity
determined using a Packard scintillation counter. The disintegra-
tions per minute (DPM) associated with HA was taken as the
difference between the counts in the control and enzyme digested
preparations and were controlled per 105 cells.
A relatively insignificant proportion (<5%) of the total syn-
thesized HA was found in the pericellular fraction under all
experimental conditions examined; data are consequently only
presented for HA present in the medium fraction.
SDS PAGE
Cell lysates from treated fibroblasts were made with RIPA buffer
using the method described in Klemke et al. (1994) and sepa-
rated by 8% SDS PAGE, under reducing conditions (Laemmli,
1970). Samples were mixed with Laemmli loading buffer (Bio-
Rad Laboratories Ltd., Hemel Hempstead, Hertfordshire UK)
containing 5% (v/v) 2-mercaptoethanol and heated for 5min at
95◦C prior to loading onto the gel. Magic Markers (Invitrogen
Ltd.) were also loaded.
WESTERN BLOTTING
SDS PAGE gels were electroblotted onto nitrocellulose at 15V
for 42min, using a Bio-Rad semi-dry blotting apparatus and
the transfer buffer 48mM Tris, 39mM glycine, 1.3mM SDS,
20% v/v methanol (Towbin et al., 1979). Buffers used during
development of the blots were based on TBS (20mM Tris-HCl,
137mM sodium chloride pH 7.6). Blots were blocked in block-
ing buffer (1% w/v low fat skimmed milk powder, 0.05% v/v
Tween 20, in TBS) for 10–30min at room temperature and then
incubated overnight at room temperature in blocking buffer,
containing anti-phospho-Akt (Ser473) antibody (Cell Signaling
Technology). Blots were then washed (3 × 20min) in TBST (TBS,
0.05% v/v Tween 20) and incubated in a 1:2000 dilution of
goat anti-rabbit HRP (Cell Signaling). Blots were then washed
(3 × 20) min in TBST and finally for 5min in TBS. Bands
were then detected by chemiluminescence using the substrate
SuperSignal West Dura (Pierce, Thermo Fisher Scientific).
IMMUNOCYTOCHEMISTRY
Cell cultures were incubated overnight in serum-free MEM and
on the following day placed in test conditions for 1 h prior to
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fixation. Medium was removed from the dishes and cells were
rinsed with TBS. Cells were incubated in 4% v/v paraformalde-
hyade at 4◦C for 20min, then washed with TBS for 5min,
three times. Cells were then washed in 0.2% Triton for 5min
and TBS again for 5min, three times. Cells were then left in
3% H2O2 at room temperature for 20min then washed in
TBS twice for 5min. Areas of the dish were circled with an
immunopen and 150μl 5% v/v Normal Goat Serum was added
to each ring for 30min. The dishes were rinsed and washed
twice with TBS for 5min. Each ring was treated with 150μl pri-
mary antibody [phospho Akt (Ser473) Cell Signaling Technology]
or negative controls and incubated in a humidified chamber at
4◦C overnight. On the following day dishes were equilibrated to
room temperature for an hour before being rinsed in TBS and
washed twice in TBST for 5min. Cells were washed for 5min
in TBS before addition of the detecting system (Signal Boost
from Cell Signaling), 1–3 drops per ring. After 30min, dishes
were rinsed with TBS, washed twice in TBST for 5min, then
TBS for 5min. Cells were incubated in DAB solution for 10min
at room temperature. To stop the reaction, dishes were rinsed
in tap water before counterstaining with Mayer’s Haematoxylin
for 30 s and Bluing Agent for 1min. Coverslips were mounted
using aqueous mount and plates viewed using a Motic BA400
microscope.
RESULTS
LOCALIZATION OF Has1, Has2, AND Has3 ex vivo STUDIES OF
DEVELOPING EMBRYONIC MOUSE PALATE
The first process of secondary palate development is shelf eleva-
tion. In the wild-type or TGFβ3 null C57 strain of mouse this
takes place around E13.5 in utero. We investigated the expres-
sion of the Has enzymes just prior to shelf elevation. Neo-natal
mouse heads were collected from E13.5 embryos either having the
wild-type or the TGFβ3 homozygous null phenotype. The H and
E sections indicate that the shelves had not elevated in both the
wild-type and knockout mouse heads (Figures 1A and B). These
were fixed, paraffin-embedded, sectioned and stained, accord-
ing to the method describe above, with antibodies raised against
Has1, Has2, and Has3 (Figures 2A–F). In the wild-type, there was
very little or no staining for Has1 in the sections at E13.5. Staining
for Has2 was intense around the epithelium and there was some
staining in the mesenchyme. Has3 was intensely stained around
the epithelium with strong staining in the mesenchyme. In the
TGFβ3 null mouse, staining for Has1 was negative. Staining for
Has2 indicated that there was some present in the epithelium and
mesenchyme but was reduced in amount. Staining for Has3 was
increased in both the epithelium and the mesenchyme compared
to the wild-type.
The second major event of secondary palatogenesis is fusion of
palatal shelves (Figures 1C andD). This usually takes place in the
developing mouse around day 14.5 in utero. We have therefore
investigated the expression of the Has enzymes as the wild-type
palates fuse. It should be noted that in the TGFβ3 null C57 strain
of mouse embryos, the shelves did not meet (Figures 3A–F).
Neo-natal mouse heads from both phenotypes were collected
and were sectioned and stained with antibodies raised against
Has1, Has2, and Has3. In the wild-type mouse, there was some
FIGURE 1 | Coronal sections of C57 Wild-type and TGFβ3 null mouse
crania stained with H&E before and after palatal shelf elevation.
Representative coronal sections of wild-type and TGFβ3 null mouse crania
at embryonic ages E13.5 and E14.5 stained with H&E are provided for
orientation purposes (A–D). The wild-type mouse sections are (A) (E13.5)
and (C) (E14.5) and the TGFβ3 null mouse sections are (B) (E13.5) and (D)
(E14.5).
staining of Has1, especially in the mesenchyme and some in the
epithelium although it was absent in the epithelial triangles. Has2
expression appears similar to that at E13.5 appearing in both the
mesenchyme and the epithelium. It appears quite intense around
the disappearing midline epithelium. The expression of Has3 is
very strong both in the epithelium and themesenchyme andmore
intense than Has2 staining in the epithelium. In the TGFβ3 null
mouse, the palatal shelves do not meet, Has1 staining is very low
and staining for Has2 was reduced in both the epithelium and
the mesenchyme. Has3 appears to be expressed quite strongly
especially when compared with Has1 and Has2.
In vitro STUDIES OF FOETAL AND ADULT FIBROBLASTS: RESPONSE TO
TGFβ3
The reduction of Has protein expression in the mouse palate
in the TGFβ3 null mouse lead to the development of our
hypothesis that HA is important in palatogenesis. Previous stud-
ies using the mouse C57 strain suggests that loss of func-
tional TGFβ3 protein always produces a cleft palate (Proetzel
et al., 1995). The interaction between TGFβ3, cell migration
and HA synthesis has been reported in the literature with
respect to adult and foetal fibroblasts (Ellis and Schor, 1998)
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FIGURE 2 | Coronal sections of C57 Wild-type and TGFβ3 null mouse
crania stained for Has expression before palatal shelf elevation (E13.5).
Wild-type (A,C and E) and TGFβ3 null (B,D and F) mouse palatal shelves at
E13.5 were stained for Has1 using a polyclonal goat anti-Has1 antibody (A),
wild-type mouse and (B), TGFβ3 null mouse, Has2 using a polyclonal goat
anti-Has2 antibody (C), wild-type mouse and (D), TGFβ3 null mouse or
Has3 using a polyclonal rabbit anti-Has3 antibody (E), wild-type mouse and
(F), TGFβ3 null mouse. Positive staining appears brown whereas negative
staining appears purple. The bars on the diagrams represent 200μm. Both
wild-type and TGFβ3 null mouse palatal shelves appeared to have low
expression for Has1. Whereas there is a slight reduction in Has2 expression
and a slight increase in Has3 expression between the wild type and the
TGFβ3 homozygous null mouse.
but their possible interaction has not been investigated in the
context of palatogenesis. The exact pathway involving TGFβ3
(and other TGFβ family members) in palatogenesis is cur-
rently unknown, but previous in vitro studies have found
that TGFβ3 affects the production of HA in human fibrob-
lasts (Ellis and Schor, 1998). During palatal fusion a num-
ber of mechanisms have been reported to be important in
the disappearance of the mid-line including EMT, apoptosis
and migration. However, which one of these mechanisms is
most important is open to debate. Our investigations have led
FIGURE 3 | Coronal sections of C57 Wild-type and TGFβ3 null mouse
crania stained for Has expression after palatal shelf elevation (E14.5).
Wild-type (A,C and E) and TGFβ3 null (B,D and F) mouse palatal shelves at
E14.5 were stained for Has1 using a polyclonal goat anti-Has1 antibody (A),
wild-type mouse and (B), TGFβ3 null mouse, Has2 using a polyclonal goat
anti-Has2 antibody (C), wild-type mouse and (D), TGFβ3 null mouse or
Has3 using a polyclonal rabbit anti-Has3 antibody (E), wild-type mouse and
(F), TGFβ3 null mouse. Positive staining appears brown whereas negative
staining appears purple. The bars on the diagrams represent 200μm. The
expression of Has1 and 2 appears reduced in the absence of TGFβ3, with
the reduction in Has2 being the greatest. Has3 expression may be slightly
increased in the absence of TGFβ3.
us to study the effect of growth factors on cell motility. Cell
migration is also affected by the addition of different TGFβ
proteins to fibroblasts. Fibroblasts from both foetal and adult
origin were isolated in the laboratory and were characterized
by their ability to respond to various members of the TGFβ
family. The addition of different TGFβ3 isoforms to fibrob-
lasts affects cell motility depending upon the confluence of the
cells and their origin (Figure 4). TGFβ3 inhibits the migration
of both adult and foetal fibroblasts plated onto the surface of
3D collagen gels at sub-confluent cell densities. However, when
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FIGURE 4 | The effects of TGFβ isoforms on the migration of foetal
and adult skin fibroblasts. Summary of the data obtained with three
lines of both foetal and adult skin fibroblasts. Cells were plated onto
collagen gels at subconfluent and confluent cell densities. Cells were
incubated with concentrations of the TGFβ isoforms which elicited then
maximal response (0.1 ng/ml TGFβ3 on confluent adult fibroblasts and
10ng/ml TGFβ2, and 3 under all other conditions). The number of cells
that had migrated into the collagen matrix after 4 days of incubation was
determined microscopically. Data are expressed as the percentage of
cells within the gel matrix.
plated at confluent cell density, foetal cells are inhibited and
adult cells stimulated to migrate into the collagen gel. Foetal
fibroblasts produce different amounts of HA in vitro (Figure 5)
and the addition of TGFβ isoforms to foetal skin fibroblasts on
collagen gels has been shown to inhibit HA synthesis but stim-
ulate HA synthesis when plated on normal tissue culture dishes
(Figure 5).
The pathways by which cells respond to growth factors were
investigated in vitro. Using a foetal fibroblast line the effect of
growth factors on HA synthesis was investigated. The amount
of HA synthesized in response to both EGF and TGFβ3 was
increased. Experiments employing a number of signal transduc-
tion pathway inhibitors found that the PI-3 kinase pathway was
important for HA synthesis (data not shown). Addition to the
assay of the inhibitor LY294002 with EGF and TGFβ3 inhib-
ited HA synthesis to background levels (Figure 6A). The PI-3
kinase pathway signals via the protein Akt, which is important
in cell migration, EMT and apoptosis. The addition, to the
cells, of increasing amounts of TGFβ3 increased Akt phospho-
rylation at Serine 473 which fully activates Akt (Figure 6B).
Immunocytochemistry of fixed cells indicated that the phos-
phorylated protein appears to translocate to the nucleus when
compared with control cells (Figures 6C-1 and C-2). Treatment
of the cells with the inhibitor LY294002 reduced the amount of
pAkt staining and also reduced the amount translocated to the
nucleus (Figure 6C-3).
DISCUSSION
The data presented indicates: (1) that the palatal shelves of the
TGFβ3 homozygous null strain of mice elevated as normal. (2)
The palatal shelves of the TGFβ3 homozygous null mouse did not
meet and therefore could not fuse. (3) Has1 staining appeared
to be present only during the fusion process of the wild-type
mouse and was absent in the TGFβ3 homozygous null mouse. (4)
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FIGURE 5 | The effects of TGFβ isoforms on HA synthesis by foetal
fibroblasts. Summary of the data obtained with three lines of foetal
fibroblasts. Cells were plated onto either collagen gels or plastic
tissue culture dishes at subconfluent and confluent cell densities. Cells
were incubated with 10 ng/ml of each of the TGFβ isoforms for 4
days. Data are expressed as [3H]-disintigrations per minute × 105 /105
cells incorporated into HA, determined as described in Ellis and Schor
(1998).
Has2 staining was present during both the elevation and fusion
processes of the wild-type mouse but reduced in the TGFβ3
null mouse. (5) Has3 staining was present during both phases
of palatal development in the wild-type mouse but only slightly
increased in the TGFβ3 null mouse. (6) The TGFβ family of
proteins affects cell migration in a cell density and cell origin
dependent manner. (7) The TGFβ family of proteins affects HA
synthesis in a matrix dependent manner. (8) TGFβ3 uses the
PI3kinase/akt pathway to affect HA synthesis.
HYALURONAN AND ITS ROLE IN PALATOGENESIS
The study of Has expression in the normal palate suggests that
Has2 and 3 are expressed in the shelves prior to elevation and
that HA is synthesized by both the epithelium and mesenchyme.
In normal palate development it has been proposed that the
main intrinsic force for elevation is provided by HA (Ferguson,
1988), which mechanically traps large quantities of water in its
large branched network structure (Scott et al., 1991), thus causing
expansion of the palatal shelves and aiding elevation. Our data
confirm that in normal palate development, HA can be synthe-
sized in the palatal shelves and does not have to be transported
from other areas. It should be noted that the shelves also elevate in
the TGFβ3 homozygous null mouse. Our data suggests that there
is a reduction in the amount of Has2 and Has3 present in these
shelves. It may be that even a small amount of these enzymes
can produce enough HA for the shelves to elevate. However,
the reduced expression of these enzymes at this time point may
effect development at a later stage, for example when the palatal
shelves are growing toward one another before fusing. Has2 syn-
thesizes high molecular weight HA (Itano et al., 1999) which has
different properties to the lower molecular weight HA synthe-
sized by Has3. Growth factors have been reported to increase the
amount of high molecular weight HA synthesized by mesenchy-
mal cells from both foetal and adult origins (Ellis et al., 1997,
1999). The ECM that cells are grown on can also affect response
to growth factors and this could explain the fact that TGFβ3
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FIGURE 6 | The effects of inhibitor LY294002 on foetal fibroblasts in
response to EGF and TGFβ3. (A) HA synthesis: foetal fibroblasts were
plated on plastic tissue culture dishes at confluent cell density in the
presence of either 10 ng/ml EGF or 0.1 ng/ml TGFβ3 and/or 1μM LY294002.
Data are expressed as [3H]-glucosamine incorporated into HA as determined
by digestion with Hyaluronan lyase. (B) SDS-PAGE and Western blotting of
TGFβ3 activation of phospho- Akt (Ser 473) phosphorylation in foetal
fibroblasts. Foetal fibroblasts were plated onto plastic tissue culture dishes.
When confluent they were serum starved and on the following day placed
into test medium. After 15min the cells were lysed and run on an 8%
SDS-PAGE. Proteins were blotted and probed with antibody against phospho-
Akt (Ser 473). Lane 1 markers, Lane 2 Blank, Lane 3 SF-MEM, Lane 4
10%FCS, Lane 5 10 pg/ml TGFβ3, Lane 6 100 pg/ml TGFβ3, Lane 7 1ng/ml
TGFβ3, Lane 8 10ng/ml TGFβ3, Lane 9 100ng/ml TGFβ3. (C) Foetal
fibroblasts plated onto 60mm tissue culture dish. After 24 h the cells were
placed in serum free overnight. The following day they were placed in test
conditions for 1 h and fixed and stained for p473 Akt. (C-1) serum free
control; (C-2) 0.1 ng/ml TGFβ3 (C-3) 0.1 ng/ml TGFβ3 and 1μM LY294002.
increases HA synthesis of foetal fibroblasts plated on plastic tissue
culture dishes but decreases it when the cells are plated on colla-
gen gels. This increase in high molecular weight HA synthesis can
be accompanied by an increase in cell migration. Addition of high
molecular weight HA increases the migration of adult fibroblasts
into 3D collagen gels suggesting that the high molecular weight
HA has roles to play in tissue development other than binding of
large amounts of water. High molecular weight HA when added
to fibroblasts plated onto the surface of 3D collagen gel causes
an increase of migration into the gel (unpublished). HA can
also influence cell behavior and development through interac-
tions with other molecules, including the HA cell surface receptor
Cluster of Differentiation 44 (CD44) (Aruffo et al., 1990) and as
part of a pericellular matrix structure (Laurent and Fraser, 1992).
Finally, the molecular weight and concentration of previously
synthesized HA located in the ECM may influence further HA
production (Smith and Ghosh, 1987). At a transcriptional level,
regulation of Has activity may occur at regions upstream of each
of the Has genes through stimulation by cytokines and other
factors (Monslow et al., 2003), such as, epidermal growth fac-
tor (EGF) (Yamada et al., 2004), transforming growth factor α
(TGFα) (Bachem et al., 1989) and members of the transforming
growth factor β (TGFβ) family (Sugiyama et al., 1998).
TGFβ3 AND ITS ROLE IN PALATOGENESIS
TGFβ3 has been found to have a vital role in palatogenesis as
TGFβ3 homozygous null mice develop a cleft palate due to a
failure in the fusion process (Proetzel et al., 1995), while the
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exogenous addition of TGFβ3 can reverse cleft palate develop-
ment in mice (Shah et al., 1995). In palatogenesis, TGFβ3 is the
first member of the TGFβ family to be expressed and it exhibits
spatial expression within the palatal shelves, which changes as
development progresses (Fitzpatrick et al., 1990). The absence of
TGFβ3 does not affect the development of any other part of the
craniofacial region in mice, which could suggest that the effect of
TGFβ3 on palatogenesis involves a primary, intrinsic mechanism
(Proetzel et al., 1995).
The exact role of TGFβ3 in palatogenesis remains unclear with
conflicting literature published on its role in adhesion of the
opposing shelves. It may also have an important role in allow-
ing the cell movement requisite for fusion (Proetzel et al., 1995;
Kaartinen et al., 1997; Martinez-Alvarez et al., 2000). TGFβ3
homozygous null mouse models have been very important in
developing an understanding of the processes involved in palato-
genesis. In general development, TGFβ3 is involved in EMT
as well as regulating a large number of cell processes includ-
ing, cell proliferation, cell differentiation and the production of
ECM (Miettinen et al., 1994). However, it is highly plausible
that there are complex interactions between many growth factors,
which may explain why different strains of TGFβ3 homozygous
null mice develop different phenotypes of cleft palate (Proetzel
et al., 1995). Many interactions have been suggested in the lit-
erature, for example, TGFβ3 may regulate palatal shelf adhesion
through chondroitin sulphate proteoglycans, which appear on the
apical surface of MEE cells just before the shelves meet (Gato
et al., 2002). It has also been suggested that TGFβ3 upregu-
lates lymphoid-enhancing factor 1 (LEF1) using Smad2,4/LEF1,
which in turn allows EMT to occur (Nawshad and Hay, 2003).
Furthermore, Xu et al. (2006), suggest that the transcription
factor Irf6 is controlled by TGFβ and that it could have an impor-
tant role in the regulation of both human and mouse MEE cells
during fusion. TGFβ family members are able to affect cell pro-
cesses by utilizing type I, type II threonine kinase receptors and
Smad proteins to affect DNA transcription (Massague, 1998). The
signals produced by these receptors must be strictly regulated
(Gritli-Linde, 2007). The role of the TGFβ type II receptor in
palatogenesis is emphasized by the development of a cleft palate
in mouse embryos lacking the TGFβ type II receptor gene (Xu
et al., 2006). In addition to the SMAD pathway, TGFβ3 has been
reported to activate the PI3kinase/akt pathway (Nawshad and
Hay, 2003). Preliminary in vitro data described here suggests that
this may be linked to HA synthesis. Previous work has reported
that the phosphorylation of Akt is important for cell motility
(Ellis et al., 2010). The data reported here indicate that this path-
way is up-regulated in response to mesenchymal cells to TGFβ3
and that blocking of this pathway also affects HA synthesis. It
remains to be determined if this response is a direct or an in direct
response of this pathway.
Many studies have focused on a number of human populations
to establish whether the role of TGFβ3 in cleft palate development
can be applicable to humans. These studies report conflicting
results, with both positive relationships (Maestri et al., 1997;
Romitti et al., 1999; Mitchell et al., 2001; Sato et al., 2001; Beaty
et al., 2002; Jugessur et al., 2003; Kim et al., 2003; Vieira et al.,
2003; Ichikawa et al., 2006; Suazo et al., 2010) and no relationship
reported (Lidral et al., 1997; Tanabe et al., 2000; Beaty et al., 2001;
Suzuki et al., 2004). Thus, it could be that TGFβ3 is of importance
in cleft palate development but only in certain populations.
CONCLUSION AND FUTURE WORK
The mechanisms that regulate shelf elevation are very important
as once the palatal shelves have changed orientation, they must
meet in the midline of the embryo in preparation for fusion.
It is likely that HA is involved in the increase in length of the
palatal shelves required for them to meet, and thus it could follow
that molecules involved in fusion have a role in regulating HA
synthesis. Many molecular factors have been suggested as having
a role in fusion, especially those with adhesion qualities, with a
review by Gritli-Linde (2007), listing over 70 genetic mutations
that have been shown to produce cleft palates. The interaction
between HA and TGFβ3 is summarized in our hypothesis
(Figure 7), where HA has a multi-functional role as a substrate
that can bind water, growth factors/proteins, cells and allows
for normal development to take place. However, changes in HA
expression or its role can lead to the development of cleft palate.
Future experiments will be to investigate Has expression in the
same strain of TGFβ3 homozygous null mouse at a later point
in development to assess whether the palatal shelves do eventu-
ally meet in the midline. The link between Has expression and
TGFβ3 in theMF1 strain mouse, where the palatal shelves meet in
the midline but do not fuse, will also be studied. This will estab-
lish whether there is a difference in Has expression in different
phenotypes of cleft palate, which have developed due to absence
of TGFβ3.
FIGURE 7 | Hypothesis: the interaction between TGFβ3 and HA is
interlinked in palatogenesis. Our working hypothesis is that HA has a role
in normal palatogenesis both in terms of hydration enabling shelf elevation
and as a matrix for cell migration and proliferation. Perturbation of growth
factors such as TGFβ3 and EGF lead to reduced synthesis of HA (or
changes in the size of HA produced) and can lead to the formation of a cleft
palate.
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The expression of Has2 can be modulated by exogenous
factors. We are in the process of creating a series of cell
lines where the expression of TGFβ3 has been silenced by
shRNA. This will enable examination, in vitro, of the fac-
tors and mechanisms controlling Has2 synthesis and also
environmental factors such as alcohol and nicotine. This
in vitro model is currently being employed to study the sig-
naling pathways important in TGFβ3 activation of the TGFβ
receptors.
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